Registration - In-house Corporation

Moderna Biopharma Canada Corporation / Stefan Raos, General Manager, Canada

Registration Information

In-house Corporation name: Moderna Biopharma Canada Corporation
Responsible Officer Name: Stefan Raos, General Manager, Canada
Responsible Officer Change History
Initial registration start date: 2021-07-05
Registration status: Active
Registration Number: 956349-370107

Associated Communications

Total Number of Communication Reports: 85

Monthly communication reports in the last 6 months: 3

Version 12 of 19 (2024-01-12 to 2024-02-14)

Registration versions:

Version 12 of 19 (2024-01-12 to 2024-02-14)

Lobbying Information

Subject Matters

Government Procurement
Health
Research and Development
Science and Technology

Subject matters added through a monthly communication report

Economic Development

Subject Matter Details

Policies or Program

Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology
Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada

Communication Techniques

Written communication
Oral communication

Government Institutions

Federal Economic Development Agency for Southern Ontario (FedDev)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Public Services and Procurement Canada (PSPC)
Treasury Board Of Canada Secretariat (TBS)

Government institutions added through a monthly communication report

Prairies Economic Development Canada (PrairiesCan)

In-house Corporation Details

Description of activities

Moderna is a biotech company focusing on vaccine technologies. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured.

Responsible officer name and position during the period of this registration

Stefan Raos, General Manager, Canada

Government funding

End date of the last completed financial year: 2023-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Investissement Quebec	$733,257.00	Yes
Ministry of Economic Development, Job Creation and Trade	$2,400,000.00	Yes

In-house Corporation Contact Information

Address:
666 Burrard Street
Suite 1700, Park Place
Vancouver, BC V6C 2X8
Canada

Telephone number: 647-503-0703

Parent Company Information

Moderna TX, Inc.
- 200 Technology Drive
  Cambridge, MA 02139
  United States of America

Subsidiary Beneficiary Information

Moderna Manufacturing Canada Corp.
- 405 Boulevard Armand-Frappier
  Laval, QC H7V 4B3
  Canada

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Laura Fitzgerald, Associate Director, Government Affairs and Policy | No public offices held
Shehzad Iqbal, Sr. Medical Director | No public offices held
Kavisha Jayasundara, Director, Market Access and Innovative Partnerships | No public offices held
Leslie Madden, Sr. Director, Regulatory Science and Quality Assurance | No public offices held
Roger Ngassam, Site Head, Canada | No public offices held
Rahbar Rahimpour, Director, R&D Strategic Alliances | No public offices held
Stefan Raos, General Manager | No public offices held
Lisa Wise-Milestone, Strategic Lead for Pandemic Preparedness Initiative | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Moderna Biopharma Canada Corporation

The following names have been used on or after July 2, 2008

Name	From	To
Moderna Biopharma Canada Corporation	2021-07-05	current

Moderna Biopharma Canada Corporation

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Stefan Raos	2023-10-19	Current
Patricia Gauthier	2021-07-05	2023-10-19

Date Modified:: 2026-02-13

Search and menus

Language selection

Registration - In-house Corporation

Moderna Biopharma Canada Corporation / Stefan Raos, General Manager, Canada

Registration Information

Associated Communications

Version 12 of 19 (2024-01-12 to 2024-02-14)

Version 12 of 19 (2024-01-12 to 2024-02-14)

Subject Matters

Subject matters added through a monthly communication report

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties